nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—Melatonin—CALR—esophageal cancer	0.0286	0.681	CrCbGaD
Rizatriptan—Apprehension—Cisplatin—esophageal cancer	0.0281	0.0455	CcSEcCtD
Rizatriptan—Facial pain—Capecitabine—esophageal cancer	0.0274	0.0443	CcSEcCtD
Rizatriptan—Temperature intolerance—Capecitabine—esophageal cancer	0.0242	0.0392	CcSEcCtD
Rizatriptan—Pain in jaw—Capecitabine—esophageal cancer	0.0122	0.0197	CcSEcCtD
Rizatriptan—Vasospasm—Capecitabine—esophageal cancer	0.0116	0.0188	CcSEcCtD
Rizatriptan—Dysaesthesia—Capecitabine—esophageal cancer	0.00918	0.0149	CcSEcCtD
Rizatriptan—Hoarseness—Capecitabine—esophageal cancer	0.00903	0.0146	CcSEcCtD
Rizatriptan—Peripheral coldness—Capecitabine—esophageal cancer	0.00834	0.0135	CcSEcCtD
Rizatriptan—Sneezing—Capecitabine—esophageal cancer	0.00717	0.0116	CcSEcCtD
Rizatriptan—Rhinorrhoea—Cisplatin—esophageal cancer	0.00665	0.0108	CcSEcCtD
Rizatriptan—Melatonin—CYP1B1—esophageal cancer	0.00623	0.149	CrCbGaD
Rizatriptan—Dysarthria—Cisplatin—esophageal cancer	0.00569	0.00922	CcSEcCtD
Rizatriptan—Hearing impaired—Cisplatin—esophageal cancer	0.00566	0.00916	CcSEcCtD
Rizatriptan—Pain—Carboplatin—esophageal cancer	0.0056	0.00907	CcSEcCtD
Rizatriptan—Tongue disorder—Capecitabine—esophageal cancer	0.00546	0.00884	CcSEcCtD
Rizatriptan—Hiccups—Cisplatin—esophageal cancer	0.00539	0.00872	CcSEcCtD
Rizatriptan—Wheezing—Cisplatin—esophageal cancer	0.00523	0.00847	CcSEcCtD
Rizatriptan—Ventricular fibrillation—Capecitabine—esophageal cancer	0.00518	0.0084	CcSEcCtD
Rizatriptan—Body temperature increased—Carboplatin—esophageal cancer	0.00518	0.00839	CcSEcCtD
Rizatriptan—Hyperaesthesia—Capecitabine—esophageal cancer	0.00506	0.00819	CcSEcCtD
Rizatriptan—Memory impairment—Capecitabine—esophageal cancer	0.00506	0.00819	CcSEcCtD
Rizatriptan—Myocardial ischaemia—Capecitabine—esophageal cancer	0.00494	0.008	CcSEcCtD
Rizatriptan—Rhinorrhoea—Capecitabine—esophageal cancer	0.0049	0.00794	CcSEcCtD
Rizatriptan—Dysphonia—Capecitabine—esophageal cancer	0.00483	0.00782	CcSEcCtD
Rizatriptan—Eye irritation—Capecitabine—esophageal cancer	0.00465	0.00753	CcSEcCtD
Rizatriptan—Melatonin—CYP19A1—esophageal cancer	0.00458	0.109	CrCbGaD
Rizatriptan—Polyuria—Cisplatin—esophageal cancer	0.00445	0.00721	CcSEcCtD
Rizatriptan—Musculoskeletal stiffness—Capecitabine—esophageal cancer	0.00443	0.00717	CcSEcCtD
Rizatriptan—Deafness—Cisplatin—esophageal cancer	0.00437	0.00708	CcSEcCtD
Rizatriptan—Lacrimation increased—Capecitabine—esophageal cancer	0.00431	0.00698	CcSEcCtD
Rizatriptan—Paralysis—Methotrexate—esophageal cancer	0.00425	0.00689	CcSEcCtD
Rizatriptan—Dysarthria—Capecitabine—esophageal cancer	0.0042	0.0068	CcSEcCtD
Rizatriptan—Hearing impaired—Capecitabine—esophageal cancer	0.00417	0.00675	CcSEcCtD
Rizatriptan—Gait disturbance—Capecitabine—esophageal cancer	0.00407	0.00659	CcSEcCtD
Rizatriptan—Coordination abnormal—Capecitabine—esophageal cancer	0.00404	0.00655	CcSEcCtD
Rizatriptan—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00404	0.00654	CcSEcCtD
Rizatriptan—Neck pain—Capecitabine—esophageal cancer	0.00402	0.00651	CcSEcCtD
Rizatriptan—Cerebrovascular accident—Cisplatin—esophageal cancer	0.00399	0.00646	CcSEcCtD
Rizatriptan—Blood pressure increased—Capecitabine—esophageal cancer	0.00397	0.00643	CcSEcCtD
Rizatriptan—Hiccups—Capecitabine—esophageal cancer	0.00397	0.00643	CcSEcCtD
Rizatriptan—Face oedema—Cisplatin—esophageal cancer	0.00377	0.00611	CcSEcCtD
Rizatriptan—Irritability—Cisplatin—esophageal cancer	0.00373	0.00604	CcSEcCtD
Rizatriptan—Dry eye—Capecitabine—esophageal cancer	0.00367	0.00594	CcSEcCtD
Rizatriptan—Dehydration—Cisplatin—esophageal cancer	0.00364	0.00589	CcSEcCtD
Rizatriptan—Urine output increased—Capecitabine—esophageal cancer	0.00359	0.00581	CcSEcCtD
Rizatriptan—Cramp muscle—Cisplatin—esophageal cancer	0.00352	0.0057	CcSEcCtD
Rizatriptan—Nasopharyngitis—Cisplatin—esophageal cancer	0.0035	0.00566	CcSEcCtD
Rizatriptan—Ear pain—Capecitabine—esophageal cancer	0.00338	0.00547	CcSEcCtD
Rizatriptan—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.00329	0.00534	CcSEcCtD
Rizatriptan—Photosensitivity—Capecitabine—esophageal cancer	0.00328	0.00532	CcSEcCtD
Rizatriptan—Polyuria—Capecitabine—esophageal cancer	0.00328	0.00532	CcSEcCtD
Rizatriptan—Swelling—Capecitabine—esophageal cancer	0.00327	0.00529	CcSEcCtD
Rizatriptan—Abdominal discomfort—Cisplatin—esophageal cancer	0.00324	0.00525	CcSEcCtD
Rizatriptan—Deafness—Capecitabine—esophageal cancer	0.00322	0.00522	CcSEcCtD
Rizatriptan—Eye pain—Capecitabine—esophageal cancer	0.00319	0.00517	CcSEcCtD
Rizatriptan—Dysarthria—Methotrexate—esophageal cancer	0.00312	0.00506	CcSEcCtD
Rizatriptan—Hot flush—Capecitabine—esophageal cancer	0.00308	0.00499	CcSEcCtD
Rizatriptan—Increased appetite—Capecitabine—esophageal cancer	0.00307	0.00497	CcSEcCtD
Rizatriptan—Menopausal symptoms—Capecitabine—esophageal cancer	0.00305	0.00495	CcSEcCtD
Rizatriptan—Thirst—Capecitabine—esophageal cancer	0.00303	0.0049	CcSEcCtD
Rizatriptan—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00297	0.00481	CcSEcCtD
Rizatriptan—Myocardial infarction—Cisplatin—esophageal cancer	0.00295	0.00478	CcSEcCtD
Rizatriptan—Cerebrovascular accident—Capecitabine—esophageal cancer	0.00294	0.00476	CcSEcCtD
Rizatriptan—Osteoarthritis—Capecitabine—esophageal cancer	0.00288	0.00467	CcSEcCtD
Rizatriptan—Face oedema—Capecitabine—esophageal cancer	0.00278	0.00451	CcSEcCtD
Rizatriptan—Bradycardia—Cisplatin—esophageal cancer	0.00275	0.00446	CcSEcCtD
Rizatriptan—Irritability—Capecitabine—esophageal cancer	0.00275	0.00445	CcSEcCtD
Rizatriptan—Ataxia—Capecitabine—esophageal cancer	0.00271	0.00439	CcSEcCtD
Rizatriptan—Dehydration—Capecitabine—esophageal cancer	0.00268	0.00434	CcSEcCtD
Rizatriptan—Urine output increased—Methotrexate—esophageal cancer	0.00267	0.00433	CcSEcCtD
Rizatriptan—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.00259	0.0042	CcSEcCtD
Rizatriptan—Nasopharyngitis—Capecitabine—esophageal cancer	0.00258	0.00417	CcSEcCtD
Rizatriptan—Gastritis—Capecitabine—esophageal cancer	0.00255	0.00413	CcSEcCtD
Rizatriptan—Sumatriptan—ABCB1—esophageal cancer	0.00255	0.0608	CrCbGaD
Rizatriptan—Muscular weakness—Capecitabine—esophageal cancer	0.00254	0.00412	CcSEcCtD
Rizatriptan—Tinnitus—Cisplatin—esophageal cancer	0.00252	0.00408	CcSEcCtD
Rizatriptan—Flushing—Cisplatin—esophageal cancer	0.00251	0.00407	CcSEcCtD
Rizatriptan—Abdominal distension—Capecitabine—esophageal cancer	0.00251	0.00406	CcSEcCtD
Rizatriptan—Dysphagia—Capecitabine—esophageal cancer	0.00249	0.00403	CcSEcCtD
Rizatriptan—Photosensitivity—Methotrexate—esophageal cancer	0.00244	0.00396	CcSEcCtD
Rizatriptan—Polyuria—Methotrexate—esophageal cancer	0.00244	0.00396	CcSEcCtD
Rizatriptan—Angina pectoris—Capecitabine—esophageal cancer	0.00243	0.00393	CcSEcCtD
Rizatriptan—Arrhythmia—Cisplatin—esophageal cancer	0.00242	0.00391	CcSEcCtD
Rizatriptan—Abdominal discomfort—Capecitabine—esophageal cancer	0.00239	0.00387	CcSEcCtD
Rizatriptan—Erythema—Cisplatin—esophageal cancer	0.00235	0.00381	CcSEcCtD
Rizatriptan—Dysuria—Capecitabine—esophageal cancer	0.00233	0.00377	CcSEcCtD
Rizatriptan—Flatulence—Cisplatin—esophageal cancer	0.00232	0.00376	CcSEcCtD
Rizatriptan—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00231	0.00375	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00227	0.00368	CcSEcCtD
Rizatriptan—Muscle spasms—Cisplatin—esophageal cancer	0.00226	0.00367	CcSEcCtD
Rizatriptan—Vision blurred—Cisplatin—esophageal cancer	0.00222	0.00359	CcSEcCtD
Rizatriptan—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00222	0.00359	CcSEcCtD
Rizatriptan—Tremor—Cisplatin—esophageal cancer	0.00221	0.00357	CcSEcCtD
Rizatriptan—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00219	0.00355	CcSEcCtD
Rizatriptan—Cerebrovascular accident—Methotrexate—esophageal cancer	0.00219	0.00355	CcSEcCtD
Rizatriptan—Myocardial infarction—Capecitabine—esophageal cancer	0.00218	0.00353	CcSEcCtD
Rizatriptan—Osteoarthritis—Methotrexate—esophageal cancer	0.00215	0.00347	CcSEcCtD
Rizatriptan—Epistaxis—Capecitabine—esophageal cancer	0.00209	0.00339	CcSEcCtD
Rizatriptan—Irritability—Methotrexate—esophageal cancer	0.00205	0.00332	CcSEcCtD
Rizatriptan—Convulsion—Cisplatin—esophageal cancer	0.00204	0.0033	CcSEcCtD
Rizatriptan—Bradycardia—Capecitabine—esophageal cancer	0.00203	0.00329	CcSEcCtD
Rizatriptan—Ataxia—Methotrexate—esophageal cancer	0.00202	0.00327	CcSEcCtD
Rizatriptan—Myalgia—Cisplatin—esophageal cancer	0.002	0.00325	CcSEcCtD
Rizatriptan—Anxiety—Cisplatin—esophageal cancer	0.002	0.00324	CcSEcCtD
Rizatriptan—Hypoaesthesia—Capecitabine—esophageal cancer	0.00198	0.00321	CcSEcCtD
Rizatriptan—Discomfort—Cisplatin—esophageal cancer	0.00198	0.00321	CcSEcCtD
Rizatriptan—Pharyngitis—Capecitabine—esophageal cancer	0.00198	0.0032	CcSEcCtD
Rizatriptan—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.00193	0.00313	CcSEcCtD
Rizatriptan—Anaphylactic shock—Cisplatin—esophageal cancer	0.00192	0.00311	CcSEcCtD
Rizatriptan—Oedema—Cisplatin—esophageal cancer	0.00192	0.00311	CcSEcCtD
Rizatriptan—Nervous system disorder—Cisplatin—esophageal cancer	0.00188	0.00305	CcSEcCtD
Rizatriptan—Tachycardia—Cisplatin—esophageal cancer	0.00188	0.00304	CcSEcCtD
Rizatriptan—Tinnitus—Capecitabine—esophageal cancer	0.00186	0.00301	CcSEcCtD
Rizatriptan—Hyperhidrosis—Cisplatin—esophageal cancer	0.00186	0.00301	CcSEcCtD
Rizatriptan—Flushing—Capecitabine—esophageal cancer	0.00185	0.003	CcSEcCtD
Rizatriptan—Anorexia—Cisplatin—esophageal cancer	0.00183	0.00297	CcSEcCtD
Rizatriptan—Angiopathy—Capecitabine—esophageal cancer	0.00181	0.00293	CcSEcCtD
Rizatriptan—Chills—Capecitabine—esophageal cancer	0.00179	0.0029	CcSEcCtD
Rizatriptan—Arrhythmia—Capecitabine—esophageal cancer	0.00178	0.00288	CcSEcCtD
Rizatriptan—Abdominal discomfort—Methotrexate—esophageal cancer	0.00178	0.00288	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00175	0.00284	CcSEcCtD
Rizatriptan—Mental disorder—Capecitabine—esophageal cancer	0.00175	0.00283	CcSEcCtD
Rizatriptan—Erythema—Capecitabine—esophageal cancer	0.00174	0.00281	CcSEcCtD
Rizatriptan—Dysuria—Methotrexate—esophageal cancer	0.00173	0.00281	CcSEcCtD
Rizatriptan—Paraesthesia—Cisplatin—esophageal cancer	0.00173	0.00279	CcSEcCtD
Rizatriptan—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00172	0.00279	CcSEcCtD
Rizatriptan—Dyspnoea—Cisplatin—esophageal cancer	0.00171	0.00277	CcSEcCtD
Rizatriptan—Flatulence—Capecitabine—esophageal cancer	0.00171	0.00277	CcSEcCtD
Rizatriptan—Dysgeusia—Capecitabine—esophageal cancer	0.0017	0.00275	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00169	0.00274	CcSEcCtD
Rizatriptan—Decreased appetite—Cisplatin—esophageal cancer	0.00167	0.00271	CcSEcCtD
Rizatriptan—Muscle spasms—Capecitabine—esophageal cancer	0.00167	0.0027	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00166	0.00269	CcSEcCtD
Rizatriptan—Pain—Cisplatin—esophageal cancer	0.00164	0.00266	CcSEcCtD
Rizatriptan—Vision blurred—Capecitabine—esophageal cancer	0.00164	0.00265	CcSEcCtD
Rizatriptan—Tremor—Capecitabine—esophageal cancer	0.00163	0.00263	CcSEcCtD
Rizatriptan—Sweating—Methotrexate—esophageal cancer	0.00158	0.00257	CcSEcCtD
Rizatriptan—Feeling abnormal—Cisplatin—esophageal cancer	0.00158	0.00256	CcSEcCtD
Rizatriptan—Epistaxis—Methotrexate—esophageal cancer	0.00156	0.00253	CcSEcCtD
Rizatriptan—Vertigo—Capecitabine—esophageal cancer	0.00156	0.00253	CcSEcCtD
Rizatriptan—Syncope—Capecitabine—esophageal cancer	0.00156	0.00252	CcSEcCtD
Rizatriptan—Palpitations—Capecitabine—esophageal cancer	0.00153	0.00248	CcSEcCtD
Rizatriptan—Loss of consciousness—Capecitabine—esophageal cancer	0.00153	0.00247	CcSEcCtD
Rizatriptan—Body temperature increased—Cisplatin—esophageal cancer	0.00152	0.00246	CcSEcCtD
Rizatriptan—Cough—Capecitabine—esophageal cancer	0.00151	0.00245	CcSEcCtD
Rizatriptan—Hypertension—Capecitabine—esophageal cancer	0.0015	0.00243	CcSEcCtD
Rizatriptan—Chest pain—Capecitabine—esophageal cancer	0.00148	0.00239	CcSEcCtD
Rizatriptan—Arthralgia—Capecitabine—esophageal cancer	0.00148	0.00239	CcSEcCtD
Rizatriptan—Myalgia—Capecitabine—esophageal cancer	0.00148	0.00239	CcSEcCtD
Rizatriptan—Pharyngitis—Methotrexate—esophageal cancer	0.00147	0.00239	CcSEcCtD
Rizatriptan—Anxiety—Capecitabine—esophageal cancer	0.00147	0.00238	CcSEcCtD
Rizatriptan—Discomfort—Capecitabine—esophageal cancer	0.00146	0.00236	CcSEcCtD
Rizatriptan—Dry mouth—Capecitabine—esophageal cancer	0.00144	0.00234	CcSEcCtD
Rizatriptan—Confusional state—Capecitabine—esophageal cancer	0.00143	0.00231	CcSEcCtD
Rizatriptan—Oedema—Capecitabine—esophageal cancer	0.00142	0.00229	CcSEcCtD
Rizatriptan—Hypersensitivity—Cisplatin—esophageal cancer	0.00142	0.00229	CcSEcCtD
Rizatriptan—Shock—Capecitabine—esophageal cancer	0.00139	0.00226	CcSEcCtD
Rizatriptan—Nervous system disorder—Capecitabine—esophageal cancer	0.00139	0.00225	CcSEcCtD
Rizatriptan—Tinnitus—Methotrexate—esophageal cancer	0.00138	0.00224	CcSEcCtD
Rizatriptan—Tachycardia—Capecitabine—esophageal cancer	0.00138	0.00224	CcSEcCtD
Rizatriptan—Asthenia—Cisplatin—esophageal cancer	0.00138	0.00223	CcSEcCtD
Rizatriptan—Hyperhidrosis—Capecitabine—esophageal cancer	0.00137	0.00222	CcSEcCtD
Rizatriptan—Anorexia—Capecitabine—esophageal cancer	0.00135	0.00219	CcSEcCtD
Rizatriptan—Angiopathy—Methotrexate—esophageal cancer	0.00135	0.00218	CcSEcCtD
Rizatriptan—Chills—Methotrexate—esophageal cancer	0.00133	0.00216	CcSEcCtD
Rizatriptan—Diarrhoea—Cisplatin—esophageal cancer	0.00131	0.00213	CcSEcCtD
Rizatriptan—Mental disorder—Methotrexate—esophageal cancer	0.0013	0.00211	CcSEcCtD
Rizatriptan—Erythema—Methotrexate—esophageal cancer	0.00129	0.00209	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00129	0.00209	CcSEcCtD
Rizatriptan—Insomnia—Capecitabine—esophageal cancer	0.00128	0.00207	CcSEcCtD
Rizatriptan—Paraesthesia—Capecitabine—esophageal cancer	0.00127	0.00206	CcSEcCtD
Rizatriptan—Dysgeusia—Methotrexate—esophageal cancer	0.00127	0.00205	CcSEcCtD
Rizatriptan—Dyspnoea—Capecitabine—esophageal cancer	0.00126	0.00205	CcSEcCtD
Rizatriptan—Dyspepsia—Capecitabine—esophageal cancer	0.00125	0.00202	CcSEcCtD
Rizatriptan—Decreased appetite—Capecitabine—esophageal cancer	0.00123	0.00199	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00122	0.00198	CcSEcCtD
Rizatriptan—Vomiting—Cisplatin—esophageal cancer	0.00122	0.00198	CcSEcCtD
Rizatriptan—Fatigue—Capecitabine—esophageal cancer	0.00122	0.00198	CcSEcCtD
Rizatriptan—Vision blurred—Methotrexate—esophageal cancer	0.00122	0.00197	CcSEcCtD
Rizatriptan—Rash—Cisplatin—esophageal cancer	0.00121	0.00196	CcSEcCtD
Rizatriptan—Constipation—Capecitabine—esophageal cancer	0.00121	0.00196	CcSEcCtD
Rizatriptan—Pain—Capecitabine—esophageal cancer	0.00121	0.00196	CcSEcCtD
Rizatriptan—Dermatitis—Cisplatin—esophageal cancer	0.00121	0.00196	CcSEcCtD
Rizatriptan—Feeling abnormal—Capecitabine—esophageal cancer	0.00117	0.00189	CcSEcCtD
Rizatriptan—Vertigo—Methotrexate—esophageal cancer	0.00116	0.00188	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00116	0.00188	CcSEcCtD
Rizatriptan—Nausea—Cisplatin—esophageal cancer	0.00114	0.00185	CcSEcCtD
Rizatriptan—Cough—Methotrexate—esophageal cancer	0.00113	0.00183	CcSEcCtD
Rizatriptan—Urticaria—Capecitabine—esophageal cancer	0.00113	0.00182	CcSEcCtD
Rizatriptan—Body temperature increased—Capecitabine—esophageal cancer	0.00112	0.00181	CcSEcCtD
Rizatriptan—Abdominal pain—Capecitabine—esophageal cancer	0.00112	0.00181	CcSEcCtD
Rizatriptan—Convulsion—Methotrexate—esophageal cancer	0.00112	0.00181	CcSEcCtD
Rizatriptan—Arthralgia—Methotrexate—esophageal cancer	0.0011	0.00178	CcSEcCtD
Rizatriptan—Chest pain—Methotrexate—esophageal cancer	0.0011	0.00178	CcSEcCtD
Rizatriptan—Myalgia—Methotrexate—esophageal cancer	0.0011	0.00178	CcSEcCtD
Rizatriptan—Discomfort—Methotrexate—esophageal cancer	0.00109	0.00176	CcSEcCtD
Rizatriptan—Confusional state—Methotrexate—esophageal cancer	0.00106	0.00172	CcSEcCtD
Rizatriptan—Anaphylactic shock—Methotrexate—esophageal cancer	0.00105	0.00171	CcSEcCtD
Rizatriptan—Hypersensitivity—Capecitabine—esophageal cancer	0.00104	0.00169	CcSEcCtD
Rizatriptan—Nervous system disorder—Methotrexate—esophageal cancer	0.00103	0.00167	CcSEcCtD
Rizatriptan—Hyperhidrosis—Methotrexate—esophageal cancer	0.00102	0.00165	CcSEcCtD
Rizatriptan—Asthenia—Capecitabine—esophageal cancer	0.00102	0.00165	CcSEcCtD
Rizatriptan—Anorexia—Methotrexate—esophageal cancer	0.00101	0.00163	CcSEcCtD
Rizatriptan—Pruritus—Capecitabine—esophageal cancer	0.001	0.00162	CcSEcCtD
Rizatriptan—Diarrhoea—Capecitabine—esophageal cancer	0.000969	0.00157	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000961	0.00156	CcSEcCtD
Rizatriptan—Insomnia—Methotrexate—esophageal cancer	0.000954	0.00154	CcSEcCtD
Rizatriptan—Paraesthesia—Methotrexate—esophageal cancer	0.000947	0.00153	CcSEcCtD
Rizatriptan—Dyspnoea—Methotrexate—esophageal cancer	0.00094	0.00152	CcSEcCtD
Rizatriptan—Somnolence—Methotrexate—esophageal cancer	0.000937	0.00152	CcSEcCtD
Rizatriptan—Dizziness—Capecitabine—esophageal cancer	0.000937	0.00152	CcSEcCtD
Rizatriptan—Dyspepsia—Methotrexate—esophageal cancer	0.000928	0.0015	CcSEcCtD
Rizatriptan—Decreased appetite—Methotrexate—esophageal cancer	0.000917	0.00148	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00091	0.00147	CcSEcCtD
Rizatriptan—Fatigue—Methotrexate—esophageal cancer	0.000909	0.00147	CcSEcCtD
Rizatriptan—Pain—Methotrexate—esophageal cancer	0.000902	0.00146	CcSEcCtD
Rizatriptan—Vomiting—Capecitabine—esophageal cancer	0.000901	0.00146	CcSEcCtD
Rizatriptan—Rash—Capecitabine—esophageal cancer	0.000893	0.00145	CcSEcCtD
Rizatriptan—Dermatitis—Capecitabine—esophageal cancer	0.000892	0.00145	CcSEcCtD
Rizatriptan—Headache—Capecitabine—esophageal cancer	0.000887	0.00144	CcSEcCtD
Rizatriptan—Feeling abnormal—Methotrexate—esophageal cancer	0.000869	0.00141	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000862	0.0014	CcSEcCtD
Rizatriptan—Nausea—Capecitabine—esophageal cancer	0.000841	0.00136	CcSEcCtD
Rizatriptan—Urticaria—Methotrexate—esophageal cancer	0.000838	0.00136	CcSEcCtD
Rizatriptan—Body temperature increased—Methotrexate—esophageal cancer	0.000833	0.00135	CcSEcCtD
Rizatriptan—Abdominal pain—Methotrexate—esophageal cancer	0.000833	0.00135	CcSEcCtD
Rizatriptan—Hypersensitivity—Methotrexate—esophageal cancer	0.000777	0.00126	CcSEcCtD
Rizatriptan—Asthenia—Methotrexate—esophageal cancer	0.000756	0.00123	CcSEcCtD
Rizatriptan—Pruritus—Methotrexate—esophageal cancer	0.000746	0.00121	CcSEcCtD
Rizatriptan—Diarrhoea—Methotrexate—esophageal cancer	0.000721	0.00117	CcSEcCtD
Rizatriptan—Dizziness—Methotrexate—esophageal cancer	0.000697	0.00113	CcSEcCtD
Rizatriptan—Vomiting—Methotrexate—esophageal cancer	0.00067	0.00109	CcSEcCtD
Rizatriptan—Rash—Methotrexate—esophageal cancer	0.000665	0.00108	CcSEcCtD
Rizatriptan—Dermatitis—Methotrexate—esophageal cancer	0.000664	0.00108	CcSEcCtD
Rizatriptan—Headache—Methotrexate—esophageal cancer	0.000661	0.00107	CcSEcCtD
Rizatriptan—Nausea—Methotrexate—esophageal cancer	0.000626	0.00101	CcSEcCtD
Rizatriptan—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000336	0.000985	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—GNG7—esophageal cancer	0.000331	0.000972	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FKBP1A—esophageal cancer	0.000329	0.000964	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000328	0.000963	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—ANXA1—esophageal cancer	0.000323	0.000949	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FKBP1A—esophageal cancer	0.000322	0.000944	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—WIF1—esophageal cancer	0.000321	0.000943	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	0.00032	0.000939	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.000319	0.000937	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000318	0.000933	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—ANXA1—esophageal cancer	0.000317	0.000929	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KMT2D—esophageal cancer	0.000316	0.000928	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CXCL2—esophageal cancer	0.000316	0.000927	CbGpPWpGaD
Rizatriptan—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000316	0.000926	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—SST—esophageal cancer	0.000314	0.000923	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—WIF1—esophageal cancer	0.000314	0.000923	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.000312	0.000917	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.000312	0.000917	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—XIAP—esophageal cancer	0.00031	0.000911	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PDE4D—esophageal cancer	0.000309	0.000908	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CXCL2—esophageal cancer	0.000309	0.000908	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—SST—esophageal cancer	0.000308	0.000904	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AKAP13—esophageal cancer	0.000307	0.000902	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—GHRL—esophageal cancer	0.000306	0.000899	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—GHRL—esophageal cancer	0.0003	0.000881	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CSNK1A1—esophageal cancer	0.000296	0.00087	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ADH1B—esophageal cancer	0.000295	0.000867	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—GNG7—esophageal cancer	0.000294	0.000864	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—ANXA1—esophageal cancer	0.000294	0.000862	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CTNNA1—esophageal cancer	0.000293	0.000861	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CXCL2—esophageal cancer	0.000292	0.000856	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CSNK1A1—esophageal cancer	0.00029	0.000852	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—ANXA1—esophageal cancer	0.000287	0.000844	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—SST—esophageal cancer	0.000286	0.000838	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—TYMP—esophageal cancer	0.000282	0.000829	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADCYAP1—esophageal cancer	0.000282	0.000827	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PDE4D—esophageal cancer	0.000281	0.000825	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—SST—esophageal cancer	0.00028	0.000821	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—GHRL—esophageal cancer	0.000278	0.000817	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PFN1—esophageal cancer	0.000277	0.000814	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CYP26A1—esophageal cancer	0.000275	0.000806	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—GHRL—esophageal cancer	0.000272	0.0008	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PSME2—esophageal cancer	0.000272	0.0008	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PSME1—esophageal cancer	0.000272	0.0008	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PFN1—esophageal cancer	0.000271	0.000797	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ANXA1—esophageal cancer	0.000271	0.000796	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ALOX15—esophageal cancer	0.000268	0.000786	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—GNG7—esophageal cancer	0.000267	0.000785	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—SST—esophageal cancer	0.000264	0.000774	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CXCL2—esophageal cancer	0.000259	0.000761	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—WWOX—esophageal cancer	0.000258	0.000756	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NOTCH3—esophageal cancer	0.000257	0.000755	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—GHRL—esophageal cancer	0.000257	0.000755	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GSTO1—esophageal cancer	0.000255	0.00075	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—TPI1—esophageal cancer	0.000255	0.00075	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—FBXW7—esophageal cancer	0.000253	0.000742	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ELMO1—esophageal cancer	0.000249	0.000731	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FKBP1A—esophageal cancer	0.000245	0.000719	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ALDOB—esophageal cancer	0.000245	0.000719	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ELMO1—esophageal cancer	0.000244	0.000716	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AKAP13—esophageal cancer	0.000243	0.000714	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—ANXA1—esophageal cancer	0.000241	0.000708	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—WIF1—esophageal cancer	0.00024	0.000703	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AKAP13—esophageal cancer	0.000238	0.000699	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GAPDH—esophageal cancer	0.000236	0.000692	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CXCL2—esophageal cancer	0.000236	0.000691	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—SST—esophageal cancer	0.000235	0.000688	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CRABP1—esophageal cancer	0.000234	0.000686	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NOTCH2—esophageal cancer	0.000231	0.000677	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—GHRL—esophageal cancer	0.000229	0.000671	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000225	0.000659	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PDE4D—esophageal cancer	0.000223	0.000653	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GNG7—esophageal cancer	0.000222	0.000652	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000222	0.000651	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CSNK1A1—esophageal cancer	0.000221	0.000649	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HIST1H2BM—esophageal cancer	0.00022	0.000646	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—ANXA1—esophageal cancer	0.000219	0.000643	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PDE4D—esophageal cancer	0.000218	0.00064	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—SST—esophageal cancer	0.000213	0.000625	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GNG7—esophageal cancer	0.000212	0.000621	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ALDH2—esophageal cancer	0.000208	0.000611	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—GHRL—esophageal cancer	0.000208	0.000609	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GNG7—esophageal cancer	0.000207	0.000608	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PFN1—esophageal cancer	0.000207	0.000607	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TGFBR2—esophageal cancer	0.000205	0.0006	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—XIAP—esophageal cancer	0.000198	0.000582	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GSTT1—esophageal cancer	0.000198	0.000581	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CYP2A6—esophageal cancer	0.000196	0.000575	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—XIAP—esophageal cancer	0.000194	0.00057	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—SMAD4—esophageal cancer	0.000194	0.000568	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000193	0.000568	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CTNNA1—esophageal cancer	0.000188	0.000551	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CXCL2—esophageal cancer	0.000187	0.000548	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ELMO1—esophageal cancer	0.000186	0.000545	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ENO1—esophageal cancer	0.000186	0.000545	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTGS1—esophageal cancer	0.000186	0.000545	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CTNNA1—esophageal cancer	0.000184	0.000539	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PSME1—esophageal cancer	0.000183	0.000537	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PSME2—esophageal cancer	0.000183	0.000537	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CXCL2—esophageal cancer	0.000183	0.000536	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKAP13—esophageal cancer	0.000182	0.000533	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PSME2—esophageal cancer	0.000174	0.000511	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PSME1—esophageal cancer	0.000174	0.000511	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ANXA1—esophageal cancer	0.000173	0.000509	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—BLVRB—esophageal cancer	0.000172	0.000505	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC52A3—esophageal cancer	0.000172	0.000505	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PSME1—esophageal cancer	0.000171	0.000501	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PSME2—esophageal cancer	0.000171	0.000501	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ANXA1—esophageal cancer	0.00017	0.000498	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SST—esophageal cancer	0.000169	0.000495	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000168	0.000492	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PDE4D—esophageal cancer	0.000166	0.000487	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SST—esophageal cancer	0.000165	0.000485	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NOTCH3—esophageal cancer	0.000164	0.000483	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—GHRL—esophageal cancer	0.000164	0.000483	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FBXW7—esophageal cancer	0.000162	0.000475	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NOTCH3—esophageal cancer	0.000161	0.000472	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—GHRL—esophageal cancer	0.000161	0.000472	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HIF1A—esophageal cancer	0.000158	0.000465	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FBXW7—esophageal cancer	0.000158	0.000465	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GNG7—esophageal cancer	0.000158	0.000464	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CYP1B1—esophageal cancer	0.000158	0.000463	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000154	0.000451	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—KDR—esophageal cancer	0.000152	0.000445	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CYP19A1—esophageal cancer	0.000148	0.000435	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—XIAP—esophageal cancer	0.000148	0.000434	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NOTCH2—esophageal cancer	0.000147	0.000433	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CA1—esophageal cancer	0.000146	0.000429	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC10A2—esophageal cancer	0.000146	0.000429	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NOTCH2—esophageal cancer	0.000144	0.000424	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NOTCH1—esophageal cancer	0.000143	0.000419	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CTNNA1—esophageal cancer	0.00014	0.000411	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCL2—esophageal cancer	0.000139	0.000408	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—HMOX1—esophageal cancer	0.000135	0.000397	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CA2—esophageal cancer	0.000134	0.000392	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TGFBR2—esophageal cancer	0.000131	0.000384	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000131	0.000384	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PSME1—esophageal cancer	0.00013	0.000381	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PSME2—esophageal cancer	0.00013	0.000381	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ABCB1—esophageal cancer	0.00013	0.000381	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CREBBP—esophageal cancer	0.000129	0.00038	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ANXA1—esophageal cancer	0.000129	0.00038	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TGFBR2—esophageal cancer	0.000128	0.000376	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—EGFR—esophageal cancer	0.000127	0.000373	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SST—esophageal cancer	0.000126	0.000369	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ADH7—esophageal cancer	0.000124	0.000365	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PLCE1—esophageal cancer	0.000124	0.000365	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SMAD4—esophageal cancer	0.000124	0.000363	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000123	0.000361	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOTCH3—esophageal cancer	0.000123	0.00036	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GHRL—esophageal cancer	0.000123	0.00036	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000122	0.000357	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SMAD4—esophageal cancer	0.000121	0.000356	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FBXW7—esophageal cancer	0.000121	0.000354	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NOS3—esophageal cancer	0.000116	0.00034	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—PIK3CA—esophageal cancer	0.00011	0.000324	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOTCH2—esophageal cancer	0.00011	0.000323	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ADH1B—esophageal cancer	0.000109	0.00032	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ERBB2—esophageal cancer	0.000108	0.000318	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—TYMP—esophageal cancer	0.000104	0.000306	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP26A1—esophageal cancer	0.000101	0.000297	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HIF1A—esophageal cancer	0.000101	0.000297	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HIF1A—esophageal cancer	9.92e-05	0.000291	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALOX15—esophageal cancer	9.87e-05	0.00029	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TGFBR2—esophageal cancer	9.76e-05	0.000286	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KDR—esophageal cancer	9.69e-05	0.000284	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CCND1—esophageal cancer	9.57e-05	0.000281	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KDR—esophageal cancer	9.49e-05	0.000278	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTO1—esophageal cancer	9.42e-05	0.000276	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—TPI1—esophageal cancer	9.42e-05	0.000276	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CDKN1A—esophageal cancer	9.26e-05	0.000272	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SMAD4—esophageal cancer	9.24e-05	0.000271	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NOTCH1—esophageal cancer	9.13e-05	0.000268	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALDOB—esophageal cancer	9.03e-05	0.000265	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NOTCH1—esophageal cancer	8.94e-05	0.000262	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—EP300—esophageal cancer	8.81e-05	0.000259	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GAPDH—esophageal cancer	8.69e-05	0.000255	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CREBBP—esophageal cancer	8.68e-05	0.000255	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CRABP1—esophageal cancer	8.61e-05	0.000253	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CREBBP—esophageal cancer	8.27e-05	0.000243	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GNG7—esophageal cancer	8.19e-05	0.000241	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—EGFR—esophageal cancer	8.13e-05	0.000239	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CREBBP—esophageal cancer	8.1e-05	0.000238	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—EGFR—esophageal cancer	7.96e-05	0.000234	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—NOS3—esophageal cancer	7.77e-05	0.000228	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—PIK3CA—esophageal cancer	7.77e-05	0.000228	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MYC—esophageal cancer	7.68e-05	0.000225	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALDH2—esophageal cancer	7.68e-05	0.000225	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—PIK3CA—esophageal cancer	7.61e-05	0.000223	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HIF1A—esophageal cancer	7.56e-05	0.000222	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—EGFR—esophageal cancer	7.51e-05	0.00022	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NOS3—esophageal cancer	7.41e-05	0.000217	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTT1—esophageal cancer	7.3e-05	0.000214	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NOS3—esophageal cancer	7.25e-05	0.000213	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KDR—esophageal cancer	7.23e-05	0.000212	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP2A6—esophageal cancer	7.22e-05	0.000212	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.19e-05	0.000211	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTGS2—esophageal cancer	7.11e-05	0.000209	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—PIK3CA—esophageal cancer	7.06e-05	0.000207	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ERBB2—esophageal cancer	6.93e-05	0.000203	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PIK3CA—esophageal cancer	6.91e-05	0.000203	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ENO1—esophageal cancer	6.84e-05	0.000201	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS1—esophageal cancer	6.84e-05	0.000201	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOTCH1—esophageal cancer	6.81e-05	0.0002	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ERBB2—esophageal cancer	6.79e-05	0.000199	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PSME1—esophageal cancer	6.74e-05	0.000198	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PSME2—esophageal cancer	6.74e-05	0.000198	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PIK3CA—esophageal cancer	6.52e-05	0.000191	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TP53—esophageal cancer	6.31e-05	0.000185	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CREBBP—esophageal cancer	6.17e-05	0.000181	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCND1—esophageal cancer	6.12e-05	0.00018	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—EGFR—esophageal cancer	6.07e-05	0.000178	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCND1—esophageal cancer	5.99e-05	0.000176	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CDKN1A—esophageal cancer	5.92e-05	0.000174	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—EP300—esophageal cancer	5.91e-05	0.000174	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.89e-05	0.000173	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP1B1—esophageal cancer	5.82e-05	0.000171	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CDKN1A—esophageal cancer	5.8e-05	0.00017	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PIK3CA—esophageal cancer	5.8e-05	0.00017	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EP300—esophageal cancer	5.64e-05	0.000165	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOS3—esophageal cancer	5.53e-05	0.000162	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EP300—esophageal cancer	5.52e-05	0.000162	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP19A1—esophageal cancer	5.47e-05	0.000161	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CA—esophageal cancer	5.26e-05	0.000155	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ERBB2—esophageal cancer	5.17e-05	0.000152	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HMOX1—esophageal cancer	4.99e-05	0.000147	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MYC—esophageal cancer	4.91e-05	0.000144	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.9e-05	0.000144	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MYC—esophageal cancer	4.81e-05	0.000141	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EGFR—esophageal cancer	4.8e-05	0.000141	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCB1—esophageal cancer	4.79e-05	0.000141	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EGFR—esophageal cancer	4.7e-05	0.000138	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCND1—esophageal cancer	4.57e-05	0.000134	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CDKN1A—esophageal cancer	4.42e-05	0.00013	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CA—esophageal cancer	4.37e-05	0.000128	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EP300—esophageal cancer	4.2e-05	0.000123	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CA—esophageal cancer	4.17e-05	0.000122	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CA—esophageal cancer	4.08e-05	0.00012	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TP53—esophageal cancer	4.03e-05	0.000118	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TP53—esophageal cancer	3.95e-05	0.000116	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MYC—esophageal cancer	3.66e-05	0.000108	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.62e-05	0.000106	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EGFR—esophageal cancer	3.58e-05	0.000105	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CREBBP—esophageal cancer	3.2e-05	9.4e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CA—esophageal cancer	3.11e-05	9.13e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TP53—esophageal cancer	3.01e-05	8.83e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NOS3—esophageal cancer	2.87e-05	8.42e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS2—esophageal cancer	2.62e-05	7.7e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—EP300—esophageal cancer	2.18e-05	6.4e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CA—esophageal cancer	1.61e-05	4.74e-05	CbGpPWpGaD
